NEW YORK, Feb. 3 (GenomeWeb News) - ViroLogic and GlaxoSmithKline have signed a 3-year, $7.5 million service agreement in which ViroLogic will provide its PhenoSense HIV co-receptor tropism assay for use in the drug giant's discovery and development efforts, the companies said today.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.